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ABSTRACT: There are a growing number of deaths of cancer patients due to toxicity of 
conventional chemotherapy. Therefore, continuous discovery of natural anticancer compounds 
with cytoselective actions would be an ideal strategy to overcome the problem. Thus, natural 
products from plant are still the alternative source in the search for anticancer drugs that can 
have a direct effect on both cancer cell removal and also minimize the side effects to the 
patients. Based on the traditional usage and pharmaceutical potential of Brucea javanica 
reported before, a study on the leaves of this plant was carried out. The aims of the study 
were to isolate the bioactive compound from B. javanica Leaves (BJL) extracts via bioassay-
guided fractionation using several selected cancer cell lines, to determine the mode of cancer 
cell death induced by BJL’s active compound and the molecular mechanism of apoptosis 
implicated in cancer cell lines by measuring the level of apoptotic protein expression such 
as bax, bcl-XL, caspase-3 and tumour suppressor p53. Among three crude extracts of BJL, 
methanol was the most potent against selected cancer cell lines which consist of cervical, 
breast, bone, ovarian and liver cancer cells. Cisplatin was used as positive control for the 
antiproliferative assay. Using a bioassay-guided fractionation, chromatography, NMR and 
mass spectrometry analysis we have isolated luteolin. It is a known compound from the 
flavonoid group which was found to be cytoselective. The IC50 value for HeLa is 8.02 
µg/ml while for Vero is >99 µg/ml. Hoechst 33258 staining and flow cytometric analysis 
of Annexin V-FITC staining revealed that luteolin induces apoptotic cell death in cervical 
Norzila et al.2016 
Health and the Environment Journal, 2016, Vol 7 No 2 
pp 116-136 
 
117 
 
cancer cell HeLa. Flow cytometric analysis also showed that luteolin induces apoptosis by 
increasing the p53, bax and caspase-3 protein expression. 
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Introduction 
 
Brucea javanica (L.) Merr. (BJ) is a shrub from family Simaroubaceae and it is known as ‘lada 
pahit’ among Malaysian due to its bitter taste. Its living locality is distributed from Southeast 
Asia to Northern Australia (Kamperdick et al., 1995; Kim et al., 2003). This plant has been used 
as traditional remedies for various types of ailments and a part of its therapeutic properties has 
been proven scientifically. Compounds from BJ have been shown to have various biological 
activities such as cytotoxic and antileukemic (Lee et al., 1979; Lee et al., 1984; Cassady and 
Suffness, 1980; Sakaki et al., 1986; Anderson et al., 1991; Fukamiya et al., 1992; Luyengi et al., 
1996; Su et al., 2002; Kim et al., 2004), antimalarial (O’Neill et al., 1987), amoebicidal (Wright 
et al., 1988), anti-protozoan (Sawangjaroen and Sawangjaroen, 2005), anti-HIV (Okano et al., 
1996), anti-inflammatory (Hall et al., 1983) and antibabesial (Subeki et al., 2007) effects. 
Chemical constituents reported from BJ included quassinoids (Polonsky et al., 1980; Kim et al., 
2003; Kim et al., 2004), quassinoid glycosides (Lee et al., 1979; Sakaki et al., 1986; Fukamiya et 
al., 1992), apotirucallane-type triterpenoids, lignan (Luyengi et al., 1996), alkaloids (Liu et al., 
1990) and alkaloid glycoside (Kitagawa et al., 1994). 
 
As there are a growing number of deaths of cancer patients due to toxicity of conventional 
chemotherapy, therefore, the cytoselectivity actions of natural anticancer compounds would be 
an ideal strategy to combat the disease. Previous investigations on the chemical constituents of 
BJ have focused mainly on the fruits and seeds. Research on other part of this plant is limited, 
especially the leaves. Moreover, the type of active compounds from BJ leaves (BJL) that 
originated from Malaysia is still not known. This is because the constituents of compounds might 
vary according to different locality, due to different climate, latitude, longitude, soil pH and soil 
texture (Amaral et al., 2010; Oloumi and Hassibi, 2011). 
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Materials and Methods 
 
Plant material 
 
B. javanica leaves were collected from Kampung Nyok Kertau, Chenor, Maran, Pahang, 
Malaysia, specifically along the riverside of Sungai Pahang. BJL were authenticated by 
Mr Shunmugan, from the Herbarium Unit, School of Biological Sciences, Universiti Sains 
Malaysia where voucher specimen (USM 11213) has been submitted for future references. 
The leaves were washed and dried in a drying oven overnight at 50oC, and were ground into 
powder. 
 
Cell lines 
 
The cell lines used for antiproliferative assay are U87 (human glioma cells), T24 (human 
bladder cancer cells), HeLa (human cervical cancer), SmGM2 (normal human bladder 
smooth muscle cells) and Vero (non-cancer of monkey kidney epithelium cell). All types of 
cells were obtained from American Type Culture Collection (ATCC), Virginia, USA. 
 
Isolation of luteolin 
 
Luteolin was isolated through bioassay-guided fractionation. Briefly, 800 grams of BJL 
powder was extracted successively using petroleum ether, methanol and water. The 
extracts from each solvent were tested for cytotoxicity towards several cancer cell lines 
(data not shown). The most active extract which is methanol, was subjected to vacuum 
liquid chromatography (VLC). The fractions from VLC were tested again on cervical 
cancer cell lines HeLa because this cell lines is the most sensitive towards methanol 
extract. The active VLC fractions were then pooled and subjected to silica gel column 
chromatography. The first pure compound managed to be isolated was a yellowish 
powder, and determined as luteolin through nuclear magnetic resonance (NMR) and mass 
spectrometric analysis; which were carried out using a Bruker (Avance) 600 MHz 
machine and Orbitrap HRESI mass spectrometer respectively. 
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Cell viability assay 
 
Antiproliferative activity was measured by methylene blue assay which was carried out 3 
days after the extract and cisplatin treatment. First, 22.5 µl of gluteraldehyde were added 
into each wells and was left on shaker for 15 min. Gluteraldehyde functions to fix the cell 
on the surface of the wells by acting on live cell membrane. Then gluteraldehyde and 
medium in the well were discarded. The microtiter plate was washed with 0.15 M NaCl 
solution 3 times to wash away dead cells, and then air-dried. Next 100 µl of 0.05% (w/v) 
methylene blue was added to each well and the plate was left on shaker for 15 min. The 
methylene blue was discarded and the plate was washed again with 0.15 M NaCl 3 times 
to wash away excess dye. After that, each well of the microtiter plate were added with 198 
µl 0.33 M HCl and the microtiter plate was left on shaker for 15 min in order to get colour 
elution. Lastly, the plate optical density (OD) was read using ELISA reader at 655 nm to 
determine the amount of live cells remained in the wells. The color intensity of methylene 
blue is directly proportional to the number of living cells. 
 
The relative viability of the treated cells as compared to the control cells was expressed as 
the percentage of live cells. IC50 value was determined from a graph of percentage of 
live cells versus log10 concentration (mg/ml) of extract. Percentage of control living cells 
was determined from the formula below: 
 
Percentage of living cells= OD treatment x 100% 
      OD negative control 
 
Apoptotic cell detection 
 
Hoechst 33258 nuclear staining assay 
 
The treated and untreated cells (0, 24, 48 and 72 hours, using the IC50 concentration of 
compound and cisplatin were trypsinized and centrifuged at 800 g to get the pellet which 
then washed with PBS. The cells were smeared onto microscope slides then fixed with 
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4% paraformaldehyde in PBS for 30 minutes at 4oC. After washing, the cells were 
incubated in Hoechst 33258 (Sigma Aldrich, St. Louis, USA) at a final concentration of 
30µg/ml at room temperature (RT) for 30 minutes. Nuclear morphology was then 
examined under a fluorescent microscope (Hishikawa et al., 1999). 
 
Apoptotic cells detection by flow cytometry 
 
The number of apoptotic cell death induced by BJL’s active compound was measured by 
flow cytometry using the BD Pharmingen
TM 
Annexin V-FITC, BD 556420 kit. The 
treated and untreated cancer cells were harvested and washed with cold PBS. The cell 
pellet was re-suspended in 1x binding buffer at a concentration of 1 x 106 cells/ml. 100 
µl of cell suspension was transferred into a tube. 5 µl of Annexin V-FITC and 5µl of 
propidium iodide were added and incubated for 15 minutes at room temperature in the dark. 
An additional 400 µl of 1x binding buffer was added to each tube. Samples were analysed 
by Beckman-Coulter FACS Calibur-500 flow cytometry within 1 hour. 100,000 events 
was acquired using green channel FL1 for Annexin V-FITC and the red channel FL3 for 
PI. 
 
Apoptotic protein detection 
 
Cells were cultured in 25 cm2 culture flasks (5% CO2, 37oC) at seeding density of 5 x 
104 cells/ml. Plates were incubated overnight before the solutions of compound and 
cisplatin were added to each well. After 24, 48 and 72 hours of exposure, cells were 
harvested by trypsinization with trypsin/EDTA solution and centrifuged at 1500 rpm. Cells 
were washed twice with 1X PBS and fixed with ice-cold 70% ethanol for 1 hour at 4oC, 
then washed twice with 1X PBS and re- suspended in blocking buffer (2% BSA) for 10 
minutes, followed by another washing step. Cell pellet was re-suspended in PBS to a 
concentration 1 x 107 cells/ml and 100 µl of cells suspension (1 x 106 cells/ml) were 
transferred into each sample tube and 20 µl of FITC/PE conjugated antibody were added 
into tubes followed by gently mixing. The antibodies used in this experiment are FITC-
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conjugated Bcl-XL, PE-conjugated Bax and PE-conjugated p53; all were purchased from 
Santa Cruz Biotechnology, Inc. The tubes were incubated at RT for 20-30 minutes in 
the dark. The pellets were washed with 2 ml of 1X PBS and the supernatant were 
discarded. Cell pellets were re-suspended in 500 µl of 1X PBS and sent to flow 
cytometric analysis. 
 
Results 
 
Isolation of luteolin 
 
The luteolin was obtained from column and thin layer chromatography techniques (Figure 
1). The pure fractions were pooled and analyzed using nuclear magnetic resonance (NMR) 
(Figure 2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: TLC profiles of fractions from column chromatography. (A) Fractions from first 
column; fraction with obvious yellow spot (13 to 21) were pooled and run to next column 
to get purer fractions. (B) Second silica gel column showed pure fractions; fraction 38 to 46.  
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Figure 2:  A: Spectrum of 
1
H NMR (400 MHz, (CD3)2CO, JS-3). A highly de-shielded hydroxyl 
proton can be seen at δ13.02 ppm, indicating the typical 5-OH of a flavone. B:  
Spectrum of 
13
C NMR (100 MHz, (CD3)2CO, JS-3). 15 carbon atoms can be seen in 
the spectrum, showing one carbonyl at 182.2 ppm, together with other 12 aromatic 
carbons, one methine at 103.4 ppm and one quaternary carbon at 164.25 ppm. C: 
Spectrum of HMBC NMR (400 MHz, (CD3)2CO, JS-3). This experiment is four 
times more sensitive that supports the 
13
C NMR. It is for highly substitute 
compound which lack sufficient protons to ‘track’ the carbons. D: Spectrum of 
HSQC NMR (400 MHz, (CD3)2CO, JS-3). The cross-peaks show protons and 
carbons that are directly connected to each other. 
 
 
Figure 3 showed the molecular structure of luteolin obtained after NMR analysis. 
A B 
C D 
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Figure 3: Molecular structure of luteolin 
 
Antiproliferative activity of luteolin 
 
The IC50 values for antiproliferative effect of luteolin towards selected cancer cell lines 
and normal cells are summarized in Table 1. The results showed that luteolin from BJ have 
cytoselective effect on cancer cells. 
 
Table 1: The IC50 values of luteolin and cisplatin for selected cancer and non-cancer cell lines. 
 
Cell types 
IC50 values (µg/ml) 
Luteolin Cisplatin 
 
HeLa 
 
8.02 ± 0.91 
 
73.95 ± 4.88 
 
T24 
 
8.33 ± 0.85 
 
>99 
 
U87 
 
10.81 ± 1.01 
 
2.20 ± 0.36 
 
SmGM2 
 
59.19 ± 5.97 
 
>99  
 
Vero 
 
>99  
 
24.64 ± 2.59 
 
 
Nuclear morphology of luteolin-induced apoptotic cell death in HeLa cells  
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DNA fragmentation is the hallmark of apoptosis cell death. To asses this, the morphological 
changes in nuclear of HeLa cells treated with luteolin (8µg/ml) was further examined using 
Hoechst 33258. This fluorescent dye binds to AT-rich regions of DNA, allowing it to be used to 
detect DNA as well as a fluorescent stain for chromosomes (Latt and Stetten, 1976; Portugal and 
Waring, 1988). Figure 4 showed fragmentation and condensation of chromatin in HeLa cells 
treated with 8µg/ml luteolin for 24, 48 and 72 hours. The untreated HeLa cells showed no 
fluorescence in the nucleus, indicating the absence of DNA fragmentation. While in treated cells, 
the density of fluorescence was increased relatively according to the time of incubation. The 
fragmented of DNA can be seen as small fluorescent spots in the nucleus.  
 
 
 
Figure 4: Representative picture of luteolin-induced apoptosis in human cervical cancer lines 
HeLa. Using Hoechst 33258 staining, the changes in nuclei of apoptotic cells can be 
observed under fluorescence microscope with magnification 40X. (A) HeLa cells 
treated with DMSO, (B) HeLa cells after treated with 8 µg/ml of luteolin for 24 hr, (C) 
48 hr and (D) 72 hr. 
 
 
A B 
C D 
Norzila et al.2016 
Health and the Environment Journal, 2016, Vol 7 No 2 
pp 116-136 
 
125 
 
A similar morphology was also observed in HeLa cells treated with 74µg/ml of cisplatin (Figure 
5). Qualitative observation showed that the intensity of fluorescence in the nucleus was increased 
in time dependent manner.  
 
   
   
Figure 5: Representative picture of cisplatin-induced apoptosis in human cervical cancer lines 
HeLa. Using Hoechst 33258 staining, the changes in nuclei of apoptotic cells can be 
observed under fluorescence microscope with magnification 40X. (A) HeLa cells 
treated with DMSO, (B) HeLa cells after treated with 74µg/ml of cisplatin for 24 hr, 
(C) 48 hr and (D) 72 hr. 
             
Flow cytometric analysis of luteolin-induced apoptotic cell death in HeLa cells 
 
Early apoptotic cells were stained positively for Annexin V- FITC that bound to 
phosphatidylserine (PS), but negative for staining with propidium iodide (PI). Late 
apoptosis or dead cells are stained positive for Annexin V-FITC and PI, whereas viable 
cells are negative for both Annexin V-FITC and PI. During early up to late apoptosis, PS is 
redistributed from inner to the outer of cell membrane (Martin et al., 1995). 
 
Figure 6 showed the flowcytometric dot plot graphs of HeLa cells treated with luteolin for 
D C 
B A 
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24, 48 and 72 hours. The Q1 region represents the population of necrotic cells, Q2 is for 
late apoptosis or dead cells, Q3 is for healthy cells and Q4 is for early apoptotic cells. 
The result demonstrated that in non-treated cells, the percentage of apoptotic cell death 
was very low (Q2 and Q4), and became increase after treated with luteolin for 24, 48 and 
72 hours. In contrast, the percentage of living cells (Q3) was gradually decreased with the 
increase of luteolin exposure time. The percentages of each cell population for 24, 48 and 
72 hours were summarized in Figure 7. 
 
                 
Figure 6: The Annexin V-FITC fluorescent staining of HeLa cells treated with 8 µg/ml 
of luteolin. Q1 represents necrotic cells, Q2 is late apoptosis or dead cell 
population, Q3 is living cell population and Q4 is early apoptotic cell population. 
(A) Cells without treatment showed the highest percentage of living cells. (B) 
Populations of cells after 24 hr treatment. (C) Populations of cells after 48h 
treatment. (D) Populations of cells after 72 hr treatment. 
A B 
C D 
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Figure 7: Percentages of cell populations for luteolin treated and non-treated cells. Q1 
represents necrotic cells, Q2 is late apoptosis or dead cell population, Q3 is living 
cell population and Q4 is early apoptotic cell population. In time dependent 
manner, the living cells were decreased, while the apoptotic cells were increased. 
Percentage of cells were analysed using Facs Diva Software Analysis and 
expressed as mean ±S.E.M of three independent experiments (P<0.05). 
 
Effects of luteolin on p53, Bax, Bcl-XL and Caspase-3 protein expression 
 
Treatment of HeLa cells with luteolin revealed the apoptotic event throughout study 
periods. This event was further elucidated for regulation of tumor suppressor protein p53, 
Bcl-2 family proteins (proapoptotic Bax and anti-apoptotic Bcl-XL) as well as caspase-
3 protein. These proteins were chosen because they determine the pathway of cell death 
event induced by luteolin. The protein expressions were analysed by flowcytometer 
summarized in Figure 8. The results also showed that the Bax: Bcl-XL ratio is increased, 
indicating apoptotic condition. 
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Figure 8 : The bar chart indicates the percentages of p53, Bax, Bcl-XL and caspase-3 
protein expression in HeLa cells after treatment of luteolin for 0, 24, 48 and 72 
hours. p53, bax and caspase-3 protein expressions are increased in time-dependent 
manner, while Bcl-XL protein expression is not significantly changed. Results 
were expressed as mean S.E.M from three independent experiment (P<0.05). 
 
Discussion 
 
Luteolin belongs to flavones type (flavonoids) of polyphenolic group of compounds. 
Phenolics compounds contain one or more aromatic rings bearing one or more hydroxyl 
group with over 8000 structural variants and generally categorized as phenolic acids and 
analogs, flavonoids, tannins, stilbenes, curcuminoids, coumarins, lignans, quinines and 
many more based on the number of phenolic rings and the structural elements that link 
those rings (Fresco et al., 2006). Flavonoids are widely distributed and coloured phenolic 
derivatives. 
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In this study, the antiproliferative activity of luteolin from BJ was as effective as 
synthetic luteolin that is reported by other reseachers (Cherng et al., 2007). However, 
according to Lahlou (2014), natural compounds have more structural diversity and novelty 
compared to synthetic compounds. Furthermore, many natural chemicals are able to 
interact with proteins, and other biological molecules. On the other hand, synthetic drugs 
can cause adverse effects with less therapeutic activity. Besides, the luteolin was obtained 
from methanolic extract of BJ via simple column chromatography which is cheaper then to 
produce it synthetically. 
 
The IC50 of HeLa in this study (28 µM) is consistent with previous research which reported 
that IC50 of luteolin for HeLa cells is 27 µM (Cherng et al., 2007). In this study, 
Cherng and colleagues have used synthetic luteolin that commercially available, which 
was also found effective in other cancer cell types, including carcinoma of the stomach, 
lung cancer and bladder cancer cells, with IC50 25µM, 41µM and 68µM respectively (Cherng 
et al., 2007).  
 
The cytotoxicity and antiproliferative activity of luteolin was reported to be associated with 
its molecular structure (Yanez et al., 2004). Yanez and colleages had conducted an in vitro 
study of cytotoxicity and antiproliferative activity of nine commercially available 
flavonoids including luteolin, quercetin, tangeretin and myricetin and they found that those 
flavonoids give different activities against melanocytes (Yanez et al., 2004). As flavonoids 
contain different hydroxyl and methoxyl group, the cancer cells react at different degrees 
of sensitivity (Yanez et al., 2004; Kuntz et al., 1999). 
 
Cisplatin was used as positive control in this study because it is a highly reactive compound, 
capable of binding DNA, RNA, proteins and membrane phospholipids. The formation of DNA 
adducts is recognized as the primary cytotoxic mechanism of cisplatin (Pasetto et al., 2006; 
Wang and Lippard, 2005). However, the antiproliferative activity of cisplatin is very low in most 
of the tested cancer cells in this study, showing the emergence of resistance towards this drug 
(O’Grady et al., 2014; Pasetto et al., 2006). 
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The four types of proteins were chosen because their expressions are very important to 
determine the apoptotic mechanism in HeLa cell death. P53 function is crucial in the 
process of mitochondrial membrane permeability which will further unleash the caspase 
cascade activation and chromatin degradation (Vaseva and Moll, 2009). Apart from that, we 
also studied the pro- apoptotic bax and anti-apoptotic bcl-XL protein expression because 
the bax: bcl-XL ratio is important to determine an apoptotic condition in cancer cells. 
The imbalance of this ratio contributes to apoptosis impairment and carcinogenesis. The 
increasing of bax:bcl-XL ratio in compound or drug-treated cancer cells reflects a good 
clinical values (Kang and Reynolds, 2009). Finally, the expression of caspase-3 protein 
was also studied because caspase-3 mediates both intrinsic and extrinsic pathway of 
apoptosis and the increase of caspase-3 protein will favour apoptosis. Caspase-3 activates 
the downstream caspases such as caspase-6 and -7 which will induce the cleavage of target 
proteins that will contribute to apoptotic features in cells (Ghobrial et al., 2005). 
 
In this study, it has clearly shown that luteolin from Brucea javanica leaves induces 
apoptosis in cervical cancer cell lines HeLa, as the morphological changes of the cells 
could be seen after treated with luteolin. The cells that undergo apoptosis would show 
morphological changes such as condensation of cytoplasm, condensation of chromatin at the 
nuclear membrane to delineated masses and cell fragmentation into apoptotic bodies (Kerr et 
al., 1972; Wyllie et al., 1980). This apoptotic morphology was supported with the 
flowcytometric analysis, showing the increase of cell the undergone apoptosis due to 
treatment of luteolin. Based on previous studies, luteolin also induces apoptosis by showing 
such morphological changes using different type of staining on various types of cancer 
cells such as liver cancer cells HepG2 and leukemia cells HL-60 (Lee et al., 2005; Cheng et 
al., 2005). 
 
Apart from apoptotic morphology, the expression of p53, Bax, Caspase-3 and Bcl-XL 
proteins were also evaluated in HeLa cells treated with luteolin. Abundants of literatures 
have reported that luteolin induce apoptosis whether via mitochondria or death receptor 
pathways in various cancer cell lines (reviewed by Seelinger et al., 2008). 
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P53 was the first tumor suppressor gene associated with apoptosis. Its mutation occur in 
the majority of human tumours  and often related to advanced tumour stage and poor 
patient prognosis (Wallace-Brodeur and Lowe, 1999). Our result showed that p53 protein 
expression in HeLa cells was increased after treated with 28µM luteolin in time 
dependent manner. The present finding seems to support the previous research by Shi et al., 
(2007); which demonstrated that luteolin-induced p53 up-regulation in HepG2 and 
HCT116 is achieved at post- transcriptional level through enhanced p53 protein 
stabilization. 
 
Conclusion 
 
The present findings demonstrated that luteolin from BJ was obtained via simple column 
chromatography displayed capability to kill cervical cancer cells through apoptosis, 
without affecting the normal cells. It is therefore suggested that luteolin from BJ leaves 
possess similar anticancer activity as reported on synthetic luteolin and luteolin from other sources. 
Hence, luteolin might be responsible for anticancer properties exhibited by BJ methanolic 
leaves extract. 
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